ADCT - Latest News

ADC Therapeutics S.A. (ADCT), operates in Healthcare / Biotechnology, trades on NYSE.

Market capitalization stands near $442.6M. Beta to the broader market is 1.84.

The article list below shows the most recent ADCT headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent ADCT Headlines

Big Pharma's 5 Hottest Biotech Hunting Grounds: Meet the Category Leaders

247wallst.com - May 14, 2026

Biotech dealmaking accelerated heading into the JPM 2026 Healthcare Conference as large drugmakers face looming patent cliffs and hunt for growth.

ADC Therapeutics: 'Strong Buy' With 2 Shots On Goal For ZYNLONTA In R/R DLBCL

seekingalpha.com - May 5, 2026

ADC Therapeutics SA remains a Strong Buy, driven by pivotal ZYNLONTA combination trials targeting 2nd-line r/r DLBCL. Topline data from the phase 3 L

ADC Therapeutics SA (ADCT) Q1 2026 Earnings Call Transcript

seekingalpha.com - May 4, 2026

ADC Therapeutics SA (ADCT) Q1 2026 Earnings Call Transcript

ADC Therapeutics SA (ADCT) Reports Q1 Loss, Beats Revenue Estimates

zacks.com - May 4, 2026

ADC Therapeutics SA (ADCT) came out with a quarterly loss of $0. 21 per share versus the Zacks Consensus Estimate of a loss of $0.

ADC Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Updates

prnewswire.com - May 4, 2026

LOTIS-5 Phase 3 topline data expected in second quarter 2026, with full data for LOTIS-5 and LOTIS-7 anticipated by year end First quarter 2026 net pr

How News Affects ADCT Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track ADCT's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked ADCT news questions

What is the latest ADCT news headline?

The most recent ADCT headline (May 14, 2026) is "Big Pharma's 5 Hottest Biotech Hunting Grounds: Meet the Category Leaders". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the ADCT news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What ADCT news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual ADCT options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.